R&D

Redx has received approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to re-commence the phase 1/2a trial for RXC004, an oral...

Last year, mergers and acquisitions activity in the life sciences sector totalled $198 billion as companies focused on building therapeutic scale and...

Eli Lily has secured marketing authorisation from NICE for Verzenios (abemaciclib) in combination with an aromatase inhibitor for treating metastatic breast cancer.